|

Irinotecan (drug) Clinical Trials

3 actively recruiting trials

Also known as: CPT-11

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

  • University of Birmingham1
  • Sun Yat-sen University1
  • Australian & New Zealand Children's Haematology/Oncology Group1

Indications

  • Cancer3
  • Childhood Solid Tumor1
  • Childhood Brain Tumor1
  • Refractory Cancer1
  • BRAF V600 Colorectal Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.